Illumina Inc (ILMN) 167.90 $ILMN Illumina to Webcast

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Illumina Inc (ILMN) 167.90 $ILMN

Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference
BusinessWire - Tue Aug 30, 2:30AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the Morgan Stanley Global Healthcare Conference in New York, NY, on September 13, 2016. The live webcast is scheduled to begin at 1:30 PM ET and will feature a brief overview of the company by Marc Stapley, Executive Vice President, Chief Administrative Officer and Chief Financial Officer, followed by a question and answer session.
ILMN: 167.90 (-0.66), MS: 31.89 (-0.02)

Illumina Keen on Genome Network Growth & Global Expansion
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:23PM CDT
On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).
HSKA: 52.49 (-0.27), ILMN: 167.90 (-0.66), ANIK: 47.89 (-0.05)

Stock Market News for August 25, 2016
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:55AM CDT
Benchmarks ended in the red on Wednesday following decline in Mylan’s shares, which had a negative impact on the biotech stocks and eventually on the broader healthcare sector
FIT: 14.96 (+0.01), ENDP: 19.82 (-0.41), VRTX: 95.11 (+0.36), GILD: 76.89 (-0.53), CEO: 123.29 (+2.65), MYL: 39.97 (-1.95), ILMN: 167.90 (-0.66), SDRL: 2.42 (+0.09), HPQ: 14.49 (-0.01), PVH: 108.56 (+0.38)

Illumina Rallies on Rumors of Takeover by Thermo Fisher
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:42AM CDT
Reportedly, Thermo Fisher (TMO) has made an all-stock offer of $30 billion to acquire Illumina (ILMN), which currently has a market cap of over $25 billion.
GWPH: 82.73 (+0.45), TMO: 151.18 (+0.23), QDEL: 21.58 (-0.16), ILMN: 167.90 (-0.66)

Downgrade Alert for Illumina (ILMN)
Comtex SmarTrend(R) - Tue Aug 23, 3:08AM CDT
Illumina (NASDAQ:ILMN) was downgraded from Buy to Neutral at CL King today. The stock closed yesterday at $173.75 on volume of 1.2 million shares, below average daily volume of 1.8 million. Illumina has overhead space with shares priced $173.75, or 1.4% below the average consensus analyst price target of $176.15. The stock should discover initial support at its 200-day moving average (MA) of $170.95 and subsequent support at its 50-day MA of $154.30.
ILMN: 167.90 (-0.66)

Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics
BusinessWire - Wed Aug 10, 5:30AM CDT
Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell next-generation sequencing (NGS) data. Under the agreement FlowJo, LLC, the producer of FlowJo, market-leading software for single cell analysis, will develop a new software application. It will provide additional secondary and tertiary analysis and visualization of datasets with an intuitive approach built on 19 years of experience working with cell biologists and immunologists in single cell phenotyping. The application will seamlessly integrate with Illumina's Single Cell RNA BaseSpace app, and provide a solution accelerating discovery.
BIO: 151.14 (+1.65), ILMN: 167.90 (-0.66)

Personal Genome Diagnostics To Collaborate With Illumina On Development Of Cancer In Vitro Diagnostic Test Kits
PR Newswire - Mon Aug 08, 6:30AM CDT
Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced an agreement with Illumina, Inc. (NASDAQ: ILMN) to develop two in-vitro diagnostic (IVD) test kits for use on Illumina's sequencing instruments, including kits for the detection and characterization of tumor DNA using both tissue and plasma samples.
ILMN: 167.90 (-0.66)

Learn how to target a 20% return on GoPro, or get option-trade ideas on Barrick Gold Corporation, Illumina, Ball Corporation and Intel or any stock you choose
PR Newswire - Fri Aug 05, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABX, BLL, GPRO, ILMN, and INTC.
GPRO: 14.13 (-0.40), ABX: 18.16 (+0.36), BLL: 80.66 (+0.81), ILMN: 167.90 (-0.66), INTC: 36.08 (+0.06)

SmarTrend Watching for Potential Pullback in Shares of Illumina After 1.97% Gain
Comtex SmarTrend(R) - Mon Aug 01, 2:06PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $166.13 to a high of $170.88. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $167.03 on volume of 454,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 167.90 (-0.66)

Illumina Set to Possibly Pullback After Yesterday's Rally of 1.97%
Comtex SmarTrend(R) - Mon Aug 01, 2:04PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $166.13 to a high of $170.88. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $167.03 on volume of 454,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 167.90 (-0.66)

Company News for July 28, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:10AM CDT
Companies In The News are: TWTR,APC,CB,ILMN
ILMN: 167.90 (-0.66), CB: 127.81 (+0.71), TWTR: 19.55 (+0.05), APC: 56.49 (+2.95)

Illumina Names Philip W. Schiller to its Board of Directors
BusinessWire - Thu Jul 28, 5:30AM CDT
Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W. Schiller has joined the company's Board of Directors. Schiller is currently Apple's Senior Vice President of Worldwide Marketing and is a member of Apple's executive team responsible for the company's product marketing, developer relations, business marketing, education marketing, international marketing and App Store programs.
ILMN: 167.90 (-0.66)

Illumina (ILMN) Beats Q2 Earnings, Revenues; EPS View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:12PM CDT
Illumina (ILMN) ended the second quarter on an outstanding note, with both the top and bottom line results comfortably beating the Zacks Consensus Estimate.
ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CYNO: 51.59 (-0.36), ILMN: 167.90 (-0.66)

Illumina Rises 8.29% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 27, 12:14PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $145.27 to a high of $163.08. Yesterday, the shares gained 8.3%, which took the trading range above the 3-day high of $152.33 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 167.90 (-0.66)

Illumina Set to Possibly Pullback After Yesterday's Rally of 8.29%
Comtex SmarTrend(R) - Wed Jul 27, 12:12PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $145.27 to a high of $163.08. Yesterday, the shares gained 8.3%, which took the trading range above the 3-day high of $152.33 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 167.90 (-0.66)

Illumina, Inc. (ILMN) - Product Pipeline Market Analysis Report, 2016: Radiant Insights
GlobeNewswire - Thu Jun 23, 5:39AM CDT
Illumina, Inc. (Illumina) provides sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company's portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations.
ILMN: 167.90 (-0.66)

Genomic Health Brings Liquid Biopsy Test for Stage IV Cancer
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:13AM CDT
Genomic's (GHDX) Oncotype SEQ facilitates personalized treatment of patients suffering from stage four solid tumor cancer.
BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59), ILMN: 167.90 (-0.66), GHDX: 27.12 (+0.45)

Illumina Announces Initial Customer Orders for the Global Screening Array
BusinessWire - Thu Jun 16, 8:00AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it has signed deals with 12 customers for its new Infinium(R) Global Screening Array (GSA). In total, the company has received orders for more than 3 million samples of the new consortia-developed array. Initial customers include human disease researchers at The Broad Institute and deCODE Genetics, health systems Avera Health, Codigo46, Diagnomics, Eone Diagnomics Genome Center (EDGC), Sanford Health and UCLA Health System, genomic service providers Centre National de Genotypage, Human Genomics Facility HuGeF, Erasmus MC, Life and Brain, and consumer genomics company 23andMe, Inc.
ILMN: 167.90 (-0.66)

Watch for Illumina to Potentially Rebound After Falling 1.06% Yesterday
Comtex SmarTrend(R) - Mon Jun 13, 2:51PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $139.41 to a high of $143.77. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $140.10 on volume of 388,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 167.90 (-0.66)

Illumina Falls 1.06% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jun 13, 2:49PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $139.41 to a high of $143.77. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $140.10 on volume of 388,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 167.90 (-0.66)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
ADFW 2026 Builds a Bigger Stage for Global Capital

Updated Category News Views 46

Abu Dhabi is not merely booking conference rooms this December; it is assembling a very deliberate display of financial muscle. Abu Dhabi Finance Week runs from 7 to 10 December 2026, and ADGM says its fifth edition will carry its largest-ever programme of partner-led activity. That is a promotional claim, sure, but the partner list is substantial enough that investors...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 97

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 175

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 60

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 57

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Food Color Industry Expected to Thrive by 2035

Updated Category News Views 167

Revitalizing the Natural Food Colors Market The natural food colors market is poised for remarkable growth, projected to expand from USD 2.01 billion to USD 4.03 billion by 2035. Market analysts suggest this surge will take place at a Compound Annual Growth Rate (CAGR) of 7.8%. This transformation is largely attributed to a shift in consumer preferences, regulatory...

Continue Reading
Fang Holdings Strengthens Leadership with Board Changes

Updated Category News Views 98

Fang Holdings Limited Announces Leadership Changes Fang Holdings Limited (OTC: SFUNY) has officially confirmed changes within its board of directors, marking an important phase for the company. As a prominent real estate Internet portal, Fang is committed to providing exceptional services to its users, and these changes in leadership are expected to support its strategic...

Continue Reading
NovaBridge's Visara Appoints Leaders to Propel Eye Treatment

Updated Category News Views 235

NovaBridge's Strategic Moves in Ophthalmology In a significant step forward for innovative treatment in ophthalmology, NovaBridge Biosciences (NASDAQ: NBP) has announced new appointments at its subsidiary, Visara, Inc. Cadmus C. Rich, MD, MBA, has been named Chief Medical Officer, while Carlos Quezada-Ruiz, MD, FASRS, takes the role of Chair of the Scientific Advisory...

Continue Reading
Celebrating Excellence: The Grossman Group's 25-Year Journey

Updated Category News Views 274

The Grossman Group Celebrates 25 Years of Communication Excellence In a prestigious recognition, The Grossman Group has earned the title of Best Small Agency at the Public Relations Society of America's 2025 Silver Anvil Awards. This honor comes during a significant milestone—the company's 25th anniversary—marked by years of dedication to enhancing internal...

Continue Reading
GiGi's Playhouse Celebrates the Opening of Its 61st Center in the Northwest

Updated Category News Views 360

GiGi's Playhouse unveiled its 61st Achievement Center back in the fall of a recent year, pushing forward its mission to uplift individuals impacted by Down syndrome. The grand opening of this center wasn’t just another launch—it was a culmination of seven years filled with passion, community spirit, and unwavering dedication from parents who aimed to create a haven...

Continue Reading